| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |